Abstract
Rates of nucleation and aggregation of calcium oxalate crystals were derived from 20-min time course measurements of OD620 after mixing solutions containing CaCl2 and K2C2O4 at 37°C, pH 5.7, ionic strength (IS) 0.21, with constant stirring (500 rpm); final assay concentrations were 4.25 mM calcium and 0.5 mM oxalate, respectively. The maximum increase of OD620 with time, termed S N, mainly reflects maximum rate of formation of new particles and thus crystal nucleation. After equilibrium has been reached, OD620 progressively decreases despite ionized calcium staying constant and no new particles being formed, due to crystal aggregation. Rate of aggregation, S A, is derived from the maximum decrease in OD620 with time. S N and S A are not independent, as indicated by a positive correlation (r=0.844, P=0.0001). Among the modifiers studied, citrate at 0.5–2.5 mM lowered both S N and S A in a concentration-dependent manner (P<0.01 for all comparisons vs control). Chondroitin-6-sulfate at 6.25–25 mg/l moderately lowered S N, whereas it strongly inhibited aggregation (P<0.01 vs control). At 6.8–20.4 mg/l, albumin did not affect nucleation, whereas it inhibited aggregation in a concentration-dependent manner (P<0.005 vs control for all comparisons).
Similar content being viewed by others
References
Brown CM, Ackermann DK, Purich DL, Finlayson B (1991) Nucleation of calcium oxalate monohydrate: use of turbidity measurements and computer-assisted simulations in characterizing early events in crystal formation. J Cryst Growth 108:455
Coe FL, Parks JH, Nakagawa Y (1991) Protein inhibitors of crystallization. Semin Nephrol 11:98
Edyvane KA, Ryall RM, Marshall VR (1987) The influence of serum and serum proteins on calcium oxalate crystal growth and aggregation. Clin Chim Acta 157:81
Finlayson B (1978) Physicochemical aspects of urolithiasis. Kidney Int 13:344
Finlayson B, Reid F (1977) The expectation of free and fixed particles in urinary stone disease. Invest Urol 15:442
Freifelder D (1976) Absorption spectroscopy. In: Freifelder D (ed) Physical biochemistry: applications to biochemistry and molecular biology. WH Freeman, San Francisco, Chap 14
Grases F, Genestar C, March P, Conte A (1988) Variations in the activity of urinary inhibitors in calcium oxalate urolithiasis. Br J Urol 62:515
Hennequin C, Lalanne V, Daudon M, Lacour B, Drueke T (1993) A new approach to studying inhibitors of calcium oxalate crystal growth. Urol Res 21:101
Hess B (1991) The role of Tamm-Horsfall glycoprotein and nephrocalcin in calcium oxalate monohydrate crystallization processes. Scanning Microsc 5:689
Hess B, Nakagawa Y, Coe FL (1989) Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 257 (Renal Fluid Electrolyte Physiol 26): F99
Kohri K, Garside J, Blacklock NJ (1989) The effect of glycosaminoglycans on the crystallisation of calcium oxalate. Br J Urol 63:584
Kok DJ (1991) The role of crystallization processes in calcium oxalate urolithiasis. PhD Thesis, University of Leiden, The Netherlands
Kok DJ, Papapoulos SE (1993) Physicochemical considerations in the development and prevention of calcium oxalate urolithiasis. Bone Miner 20:1
Kok DJ, Papapoulos SE, Blomen LJMJ, Bijvoet OLM (1988) Modulation of calcium oxalate monohydrate crystallization kinetics in vitro. Kidney Int 34:346
Madsen S, Olgaard K (1977) Evaluation of a new automatic calcium ion analyzer, Clin Chem 23:690
Melik DH, Fogler HS (1983) Turbidimetric determination of particle size distributions of colloidal systems. J Coll Interf Sci 92:161
Nielsen AE (1955) The kinetics of polyelectrolyte precipitation. J Coll Sci 10:576
Robertson WG, Peacock M, Nordin BEC (1969) Calcium crystalluria in recurrent renal stone formers. Lancet II:21
Robertson WG, Scurr DS (1986) Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystallizer using an artificial urine. J Urol 135:1322
Ryall RL, Harnett RM, Marshall VR (1981) The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 112:349
Ryall RL, Harnett RM, Hibberd CM, Edyvane KA, Marshall VR (1991) Effects of chondroitin sulphate, human serum albumin and Tamm-Horsfall mucoprotein on calcium oxalate crystallization in undiluted human urine. Urol Res 19:181
Scurr DS, Robertson WG (1986) Modifiers of calcium oxalate crystallization found in urine. II. Studies on their mode of action in an artificial urine. J Urol 136:128
Worcester EM, Nakagawa Y, Wabner CL, Kumar S, Coe FL (1988) Crystal adsorption and growth slowing by nephrocalcin, albumin, and Tamm-Horsfall protein. Am J Physiol 255 (Renal Fluid Electrolyte Physiol 24):F1197
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hess, B., Meinhardt, U., Zipperle, L. et al. Simultaneous measurements of calcium oxalate crystal nucleation and aggregation: impact of various modifiers. Urol. Res. 23, 231–238 (1995). https://doi.org/10.1007/BF00393304
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00393304